Statement of Changes in Beneficial Ownership (4)
January 21 2020 - 2:00PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
McCall Thomas D |
2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE
[
ICUI
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Vice President and Gen'l Mgr. |
(Last)
(First)
(Middle)
951 CALLE AMANECER |
3. Date of Earliest Transaction
(MM/DD/YYYY)
1/17/2020 |
(Street)
SAN CLEMENTE, CA 92673
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 1/17/2020 | | M | | 3153 | A | $0.0 | 9539 | D | |
Common Stock | 1/17/2020 | | F | | 1698 | D | $0.0 | 7841 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Common Stock (1) | $0.0 (2) | 1/17/2020 | | M | | | 1051 (3) | 1/17/2020 (4) | 12/31/2019 | Common Stock | 3153 | $0.0 | 0 | D | |
Explanation of Responses: |
(1) | These Securities are Performance-based Restricted Stock Units (PRSU). |
(2) | There is neither a purchase price nor an exercise price for the PRSUs. |
(3) | Each PRSU reflects the contingent right to receive a variable number of shares of common stock based on achieving performance goals. At the determination date, based on certification of the achievement of the performance criteria, the reporting person earned 300% of the target award amount. |
(4) | These PRSUs were granted on March 27, 2017. The vesting for this performance-based restricted stock unit ("PRSU") award was dependent upon the achievement of a minimum Cumulative Adjusted EBITDA over the Fiscal Years 2017-2019. The reporting person was able to earn PRSUs ranging from 100% to 300% of the target award amount. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
McCall Thomas D 951 CALLE AMANECER SAN CLEMENTE, CA 92673 |
|
| Vice President and Gen'l Mgr. |
|
Signatures
|
By: Paula Darbyshire, Attorney-In-Fact For: Thomas D. McCall | | 1/21/2020 |
**Signature of Reporting Person | Date |
ICU Medical (NASDAQ:ICUI)
Historical Stock Chart
From Jun 2024 to Jul 2024
ICU Medical (NASDAQ:ICUI)
Historical Stock Chart
From Jul 2023 to Jul 2024